James George Robinson, Director at NYMOX PHARMACEUTICAL CORP (NYMX), bought 2,303,030 shares at $1.65 ($3.8M) on 2022-05-02, disclosed to the SEC on 2022-05-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.65 | 1,151,515 | $1.9M | 50.0% |
| 2 | $1.65 | 1,151,515 | $1.9M | 50.0% |
| Total | $1.65 avg | 2,303,030 | $3.8M | 100% |
| Filing → |
| NYMX | BUY | 2021-04-27 | $83K | — | Filing → |
| NYMX | BUY | 2019-07-12 | $12K | — | Filing → |
| NYMX | BUY | 2019-07-10 | $11K | — | Filing → |